International plasma
protein congress (IPPC)

A networking Welcome reception will be held the night prior to the conference for meeting attendees. The reception will be held 18:00 - 20:00 (GMT+2) at the Athens Marriott Hotel in the garden/atrium.
‍
Sponsored by ImmunoTek Bio Centers

TIME (GMT+2)
07:30 - 17:30
On-site registration open
‍
08:30-09:00
Welcome & Opening ceremony

Maarten Van Baelen, Executive Director - PPTA Europe

Anita Brikman, President & CEO - PPTA

Adonis Georgiadis, Minister of Health - Greece
‍
09:00 - 09:20
From Donor to Patient: Plasma-derived Medicines Uniquely Saving Lives
Moderator: Anita Brikman, President & CEO - PPTA
‍
Nancy Di Salvo, Director International Affairs - GBS-CIDP Foundation International

Martin Moll, University Teacher - University of Graz; Plasma donor

09:20 - 10:40
SESSION 1: Real-World Evidence on the Safety of Plasma Donation  
Moderator: Torsten Tonn, Medical Director and CEO - German Red Cross Blood Donation Service

Explore donor safety in this session. Hear from experts on harmonizing approaches to consistent donor frequency and optimizing plasma collection across the EU, and even different plasmapheresis practices.
‍
‍Katja van den Hurk, Head of Donor Studies, Principal Investigator Donor Health; Epidemiologist - Sanquin

Johanna Castrén, Chair - European Committee on Blood Transfusion
‍
‍Stephan T. Kiessig,, Chief Medical Officer - Previpharma

Jan Hartmann, Chief Medical Officer - Haemonetics

10:40 - 11:30
Networking Break Sponsored by Fresenius Kabi USA

11:30 - 12:45
SESSION 2: Recruiting to Return: Motivating a Comprehensive Commitment
Moderator: Peter Jaworski, Associate Teaching Professor - Georgetown University

In this session, industry leaders explore lessons learned around donor recruitment and retention. Hear the importance of helping donors understand their important impact on the health and well-being of patients.
‍
Gerry Gogarty, Director Plasma for Medicines - NHS Blood and Transplant England
‍
Zsofia Bacsadi, PhD student in Sociology and Social Anthropology - Central European University Vienna; Plasma donor

Britta Diebel, Manager Communications Plasma Europe - Haema Blut & Plasma
‍
Oksana Muliarchuk - Biopharma Plasma

Martin Moll - University Teacher - University of Graz; Plasma donor

12.45 - 14:00
Networking Lunch Sponsored by Paysign

14:00 - 15:15
SESSION 3: SoHO Regulation - What's Next?
Moderator: Vasiliki Angouridi, Health Editor - News4Health.gr & Euractiv.com

Experts take the stage to discuss SoHO's role in enhancing plasma donations to ultimately improve patient access to plasma-derived medicinal products in the EU.

Beatrice Marquez-Garrido, Policy Officer, Substances of Human Origin - European Commission

Janina Hahnloser, Consultant for Blood, Blood Products, Plasma and Tissues - German Ministry of Health

Jakub Dvořáček, Deputy Minister for Health - Czech Republic
‍
Richard Forde, Scientific Programme Manager - EDQM

Milan Maly, Managing Director - UnicaPlasma; Chair - European Plasma Alliance

15:15 - 16:00
Networking Break Sponsored by Fresenius Kabi USA

16:00 - 17:15
SESSION 4: Inspections: Role in Global Quality Management
Moderator: James Knowles, Head Global Regulatory Affairs - PPTA
‍
In this session, experts will discuss the key roleinspections play in quality management of plasma and PDMPs, with a focus on existing challenges, opportunities to facilitate timely inspections, aswell as harmonization efforts to improve availability of plasma formanufacturing of PDMPs. 

Karmin Saadat, GMP inspector - AGES Austria

Robert Weiss, Head - BioLife Quality Europe

Ute Krahl, IQPP Auditor

James Knowles, Head Global Regulatory Affairs - PPTA

17:15 - 17:30
‍End of Day Closure and Presentation of the 2024 Joachim Hilfenhaus Award
‍
Ferdinando Borgese, Commercial Director Intercontinental - Kedrion Biopharma and Chair of PPTA Europe

20:15 - 22:30
Networking Dinner at the Acropolis Museum
https://www.theacropolismuseum.gr/en/‍
‍

TIME (GMT+2)
08:00 - 15:00
On-site registration open
‍
09:00 - 09:30
Day Two Kickoff and Welcome

Maarten Van Baelen, Executive Director - PPTA Europe

Giles Platford, President, Plasma-Derived Therapies Business Unit at Takeda & Chair of the Global Executive Board at PPTA

09:30 - 10:45
SESSION 5: Striving Toward Strategic Autonomy in the EU
Moderator: Maarten Van Baelen, Executive Director - PPTA Europe
‍
With approximately 40% of plasma is currently sourced from the United States, what can be done to increase the region's self-sufficiency?  This session will incorporate perspectives from the public, private, and third sectors to identify strategies that ensure patient access to PDMPs.

Matthew Hotchko, President - Marketing Research Bureau
‍
Jean-Philippe Plançon, CEO - EPODIN

Eva-Maria Merz, Full Professor, Researcher - Vrije Universiteit Amsterdam, Sanquin Blood Supply

Fabio Candura, Director Plasma and Plasma-derived Medicinal Products Area - National Blood Centre - National Institute of Health Italy

Svenja Tatjana Barckhausen, Executive Board Member - Haema

10:45 - 11:30
Networking Break Sponsored by Paysign

11:30 - 12:45
SESSION 6: Strengthening the Supply Chain for Plasma-derived Medicines
Moderator: Sarah-Taïssir Bencharif, Physician and Health Care Journalist

Increased focus on pharmaceutical supply chains resulted in numerous initiatives and actions at national, EU and pan-European levels analysing the challenges and opportunities for enhancing the resilience and security of medicinal products supply. The session will aim to discuss different organisations and the industry's efforts in strengthening pharmaceutical supply chains and define the opportunities for further enhancing the availability of plasma-derived therapies for patients in the EU.
‍
Cemre Balaban, Junior Trade Policy Analyst, Trade Policy Division, Trade and Agriculture Directorate - OECD

Klaus Kruttwig, Medicines and Medical Devices Shortages Specialist - European Medicines Agency

Stelios Kympouropoulos, Member of European Parliament - EPP

Domenico Di Giorgio, Head of Inspection and Certification Department and of the Pharmaceutical Crime Counteracting Office - AIFA

Thomas Heynisch, Policy Coordinator, DG GROW - Food, Retail, Health – European Commission

Ferdinando Borgese, Commercial Director Intercontinental - Kedrion Biopharma and Chair of PPTA Europe

12:45 - 14:00
Networking Lunch

14:00 - 15:15
SESSION 7: Appropriate Use of IgGs
Moderator: Tomasz Kluszczynski, Strategy Consultant, Guest Professor - Warsaw University of Technology and Goethe Frankfurt University

Due to its unique and finite source material of human plasma, the IgG supply chain from donor to patient is extremely fragile and subject to disruptions, especially in crisis situations such as the COVID-19 pandemic. In this session, take a deep dive into how to evaluate the growing medical need and demand -- versus the finite availability of plasma -- based on the optimal and appropriate use of IgGs.
‍
Johan Prevot, Executive Director - IPOPI

Silvia Sanchez Ramon, Head of Immunology Department- Hospital Clínico San Carlos, Universidad Complutense of Madrid

Isabelle Durand-Zaleski - Professor in Public Health, Université de Paris; Head of the Paris Health Economics and Health Services Research Unit

Marek Migdal, CEO - Children’s Memorial Health Institute Warsaw

Daniela Philadelphy, Chair of the Haematology Working Party, CHMP member - AGES Austria

15:15 - 15:30
End and closure of IPPC 2024

Maarten Van Baelen, Executive Director - PPTA Europe